Adeona reports $3.

Adeona reports $3,164,512 net revenue for 2010 2010 Adeona Pharmaceuticals, Inc. , a programmer of innovative medications for serious central anxious system diseases, december 31 reported its financial results for the year ended, 2010, in addition to updates since the beginning of the 4th quarter ed drugs . Updates because the beginning of the 4th quarter include: Clinical Programs Alzheimer's Disease Adoption of reaZin as the brand new trademark for Adeona's zinc and cysteine-based oral tablet currently under advancement seeing that a prescription medical food for the dietary administration of Alzheimer's disease and mild cognitive impairment.

However, aspirin by itself won’t treat a heart attack and emergency medical assistance is necessary to lessen damage the effect of a heart attack and to potentially save lives. Based on the study commissioned by McNeil Customer & Specialty Pharmaceuticals, 84 % of the National Association of Emergency Medical Technicians say it is standard protocol to give aspirin to a conscious patient during a suspected coronary attack; however, no more than one-third of these surveyed know that the FDA offers guidelines on the utilization and correct dosage of aspirin for sufferers suffering a suspected coronary attack.